KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $38.1 billion.

  • Elevance Health's Cost of Revenue rose 1362.69% to $38.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $148.2 billion, marking a year-over-year increase of 1619.23%. This contributed to the annual value of $148.2 billion for FY2025, which is 1619.23% up from last year.
  • Per Elevance Health's latest filing, its Cost of Revenue stood at $38.1 billion for Q4 2025, which was up 1362.69% from $38.1 billion recorded in Q3 2025.
  • Elevance Health's Cost of Revenue's 5-year high stood at $38.1 billion during Q3 2025, with a 5-year trough of $23.7 billion in Q1 2021.
  • Its 5-year average for Cost of Revenue is $31.0 billion, with a median of $30.6 billion in 2023.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 2668.44% in 2021, then plummeted by 326.54% in 2024.
  • Elevance Health's Cost of Revenue (Quarter) stood at $27.5 billion in 2021, then increased by 9.94% to $30.2 billion in 2022, then rose by 3.77% to $31.3 billion in 2023, then increased by 6.91% to $33.5 billion in 2024, then grew by 13.63% to $38.1 billion in 2025.
  • Its Cost of Revenue stands at $38.1 billion for Q4 2025, versus $38.1 billion for Q3 2025 and $36.7 billion for Q2 2025.